enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dabigatran - Wikipedia

   en.wikipedia.org/wiki/Dabigatran

   Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. [ 6 ] [ 7 ] Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. [ 6 ]

3. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Direct factor Xa inhibitors (xabans) are anticoagulants (blood thinning drugs), used to both treat and prevent blood clots in veins, and prevent stroke and embolism in people with atrial fibrillation (AF). [2] [3]

4. Discovery and development of direct thrombin inhibitors

   en.wikipedia.org/wiki/Discovery_and_development...

   In October 2010 the US FDA approved dabigatran etexilate for the prevention of stroke in patients with atrial fibrillation (AF). [6] [10] Many pharmaceutical companies have attempted to develop orally bioavailable DTI drugs but dabigatran etexilate is the only one to reach the market. [9]

5. Direct thrombin inhibitor - Wikipedia

   en.wikipedia.org/wiki/Direct_thrombin_inhibitor

   Dabigatran is an oral direct thrombin inhibitor. Dabigatran (Pradaxa) was found to be noninferior to Warfarin in prevention of ischemic stroke, as well as intracranial hemorrhage risk and overall mortality for non-valvular atrial fibrillation according to the RE-LY trial. [9]

6. Stroke could cause nearly 10 million deaths per year by 2050 ...

   www.aol.com/stroke-could-cause-nearly-10...

   The number of people who die from stroke worldwide will jump 50% by 2050 if no significant action is taken to limit the prevalence of stroke and its risk factors, according to a new report from ...

7. Stroke may cause 10 million deaths a year globally by 2050 ...

   www.aol.com/news/stroke-may-cause-10-million...

   Costs associated with stroke in the US could hit $2.3 trillion by 2050, up from $891 billion in 2020 Stroke may cause 10 million deaths a year globally by 2050, new research finds Skip to main content

8. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

9. Obesity drug Wegovy is approved to cut heart attack and ... - AOL

   www.aol.com/news/obesity-drug-wegovy-approved...

   The decision was based on the results of a study that found that Wegovy cut the risk of serious heart problems — including heart attack, stroke and heart-related deaths. Higher-weight patients ...